| abstract |
A pharmaceutical composition comprising (S) -5- {3- [4- (4-chlorophenyl) -4-hydroxy-3,3-dimethyl-piperidin-1-yl] -propylidene} -5,11-dihydro- 10-oxa-1-aza-dibenzo [a, d] cycloheptene-7-carboxylic acid or a physiologically acceptable salt thereof, (R) -5- {3- [4- (4-chloro-phenyl) -4- hydroxy-3,3-dimethyl-piperidin-1-yl] -propylidene} -5,11-dihydro-10-oxa-1-aza-dibenzo [a, d] cycloheptene-7-carboxylic acid or a physiologically acceptable salt thereof , and a physiologically acceptable carrier or excipient, in which the ratio of enantiomer (S) in the enantiomer (R) is at least 2: 1. |